| dc.creator | Rosa, Robert | |
| dc.creator | Roddy, Gavin W. | |
| dc.creator | Prockop, Darwin J. | |
| dc.date.accessioned | 2019-06-17T17:09:52Z | |
| dc.date.available | 2019-06-17T17:09:52Z | |
| dc.date.issued | 2015-07-28 | |
| dc.identifier.uri | https://hdl.handle.net/1969.1/177110 | |
| dc.description.abstract | The present invention encompasses methods, compositions, and devices for treating an ocular disease, disorder or condition in a mammal. The invention includes polypeptides that possess anti-inflammatory, anti-apoptotic, immune modulatory and anti-tumorigenic properties, and their application in the treatment of eye disease, particularly diseases of the retina. In particular aspects, the invention includes administration of a therapeutic polypeptide such as a stanniocalcin family member protein for the treatment of an eye disease. Also included are fusion proteins and cells stimulated or modified to express the therapeutic polypeptides as set forth herein. | en |
| dc.language | eng | |
| dc.publisher | United States. Patent and Trademark Office | |
| dc.rights | Public Domain (No copyright - United States) | en |
| dc.rights.uri | http://rightsstatements.org/vocab/NoC-US/1.0/ | |
| dc.title | Protein therapy for treatment of retinal diseases | en |
| dc.type | Utility patent | en |
| dc.format.digitalOrigin | reformatted digital | en |
| dc.description.country | US | |
| dc.contributor.assignee | Scott & White Healthcare | |
| dc.contributor.assignee | The Texas A&M University System | |
| dc.identifier.patentapplicationnumber | 14/284911 | |
| dc.date.filed | 2014-05-22 | |
| dc.publisher.digital | Texas A&M University. Libraries | |
| dc.subject.cpcprimary | C07K 14/575 | |
| dc.subject.cpcprimary | A61K 35/28 | |
| dc.subject.cpcprimary | A61K 38/1709 | |
| dc.subject.cpcprimary | A61K 38/22 | |
